{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:44:34Z","timestamp":1790700274873,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010977","name":"Cognitive Neuroscience Society","doi-asserted-by":"publisher","award":["1.79,81.92"],"award-info":[{"award-number":["1.79,81.92"]}],"id":[{"id":"10.13039\/100010977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010977","name":"Cognitive Neuroscience Society","doi-asserted-by":"publisher","award":["\u00b112.3"],"award-info":[{"award-number":["\u00b112.3"]}],"id":[{"id":"10.13039\/100010977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010977","name":"Cognitive Neuroscience Society","doi-asserted-by":"publisher","award":["\u00b113.1"],"award-info":[{"award-number":["\u00b113.1"]}],"id":[{"id":"10.13039\/100010977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.antiviral.2021.105083","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T11:44:24Z","timestamp":1620215064000},"page":"105083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Clinical outcome and the role of antivirals in congenital cytomegalovirus infection"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8244-8025","authenticated-orcid":false,"given":"Shannon A.","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kimberlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2021.105083_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1386-6532(00)00089-5","article-title":"Cytomegalovirus DNA detection in Guthrie cards: a powerful tool for diagnosing congenital infection","volume":"17","author":"Barbi","year":"2000","journal-title":"J. Clin. Virol."},{"issue":"5","key":"10.1016\/j.antiviral.2021.105083_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.1938","article-title":"Hearing and neurodevelopmental outcomes for children with asymptomatic congenital cytomegalovirus infection: a systematic review","volume":"27","author":"Bartlett","year":"2017","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2021.105083_bib3","doi-asserted-by":"crossref","first-page":"e887","DOI":"10.1542\/peds.2015-0908","article-title":"Vestibular disorders in children with congenital cytomegalovirus infection","volume":"136","author":"Bernard","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.antiviral.2021.105083_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: a randomized clinical trial","volume":"34","author":"Bernstein","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2021.105083_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00006454-199202000-00007","article-title":"Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality","volume":"11","author":"Boppana","year":"1992","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.antiviral.2021.105083_bib6","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jama.2010.423","article-title":"Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection","volume":"303","author":"Boppana","year":"2010","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.antiviral.2021.105083_bib7","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa1006561","article-title":"Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns","volume":"364","author":"Boppana","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2021.105083_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1515\/jpm-2011-0257","article-title":"Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis","volume":"40","author":"Buxmann","year":"2012","journal-title":"J. Perinat. Med."},{"issue":"Suppl. 4","key":"10.1016\/j.antiviral.2021.105083_bib9","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jcv.2009.09.002","article-title":"Congenital cytomegalovirus (CMV) epidemiology and awareness","volume":"46","author":"Cannon","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2021.105083_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-0042-1748054","article-title":"Longitudinal investigations of hearing disorders in children with congenital cytomegalovirus","volume":"11","author":"Dahle","year":"2000","journal-title":"J. Am. Acad. Audiol."},{"key":"10.1016\/j.antiviral.2021.105083_bib11","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/INF.0b013e3181723d55","article-title":"Congenital cytomegalovirus infection in a highly seropositive semi-urban population in India","volume":"27","author":"Dar","year":"2008","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"Suppl. 4","key":"10.1016\/j.antiviral.2021.105083_bib12","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.jcv.2009.09.001","article-title":"Evaluation of DNA extraction methods for dried blood spots in the diagnosis of congenital cytomegalovirus infection","volume":"46","author":"de Vries","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2021.105083_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/AUD.0000000000000904","article-title":"Vestibular function in children with a congenital cytomegalovirus infection: 3 Years of follow-up","volume":"42","author":"Dhondt","year":"2020","journal-title":"Ear Hear."},{"key":"10.1016\/j.antiviral.2021.105083_bib14","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0789","article-title":"Outcomes from a hearing-targeted cytomegalovirus screening program","volume":"139","author":"Diener","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.antiviral.2021.105083_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2020.5441","article-title":"Sensitivity of dried blood spot testing for detection of congenital cytomegalovirus infection","author":"Dollard","year":"2021","journal-title":"JAMA pediatrics"},{"key":"10.1016\/j.antiviral.2021.105083_bib16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2021.105083_bib17","first-page":"39","article-title":"Losing ground: awareness of congenital cytomegalovirus in the United States","volume":"1","author":"Doutre","year":"2016","journal-title":"The Journal of Early Hearing Detectin and Intervention"},{"key":"10.1016\/j.antiviral.2021.105083_bib18","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jpeds.2013.12.007","article-title":"Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection","volume":"164","author":"Dreher","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.antiviral.2021.105083_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-3476(99)70328-8","article-title":"Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed?","volume":"135","author":"Fowler","year":"1999","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.antiviral.2021.105083_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2016-2128","article-title":"A targeted approach for congenital cytomegalovirus screening within newborn hearing screening","volume":"139","author":"Fowler","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.antiviral.2021.105083_bib21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jpeds.2018.04.043","article-title":"Racial and ethnic differences in the prevalence of congenital cytomegalovirus infection","volume":"200","author":"Fowler","year":"2018","journal-title":"J. Pediatr."},{"key":"10.1016\/j.antiviral.2021.105083_bib22","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamapediatrics.2016.2016","article-title":"Cost-effectiveness of universal and targeted newborn screening for congenital cytomegalovirus infection","volume":"170","author":"Gantt","year":"2016","journal-title":"JAMA pediatrics"},{"key":"10.1016\/j.antiviral.2021.105083_bib23","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1542\/peds.2014-1173","article-title":"Hearing loss and congenital CMV infection: a systematic review","volume":"134","author":"Goderis","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.antiviral.2021.105083_bib24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jpeds.2016.01.024","article-title":"Hearing in children with congenital cytomegalovirus infection: results of a longitudinal study","volume":"172","author":"Goderis","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.antiviral.2021.105083_bib25","doi-asserted-by":"crossref","first-page":"S1000","DOI":"10.1093\/ofid\/ofz415.2500","article-title":"Randomized trial to prevent congenital cytomegalovirus (CMV)","volume":"6","author":"Hughes","year":"2019","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1016\/j.antiviral.2021.105083_bib26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/AOG.0000000000002216","article-title":"A brief prenatal intervention of behavioral change to reduce the risk of maternal cytomegalovirus: a randomized controlled trial","volume":"130","author":"Hughes","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.antiviral.2021.105083_bib27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2021.105083_bib28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jpeds.2010.03.002","article-title":"Use of screening dried blood spots for estimation of prevalence, risk factors, and birth outcomes of congenital cytomegalovirus infection","volume":"157","author":"Kharrazi","year":"2010","journal-title":"J. Pediatr."},{"key":"10.1016\/j.antiviral.2021.105083_bib29","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1086\/528376","article-title":"Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease","volume":"197","author":"Kimberlin","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2021.105083_bib30","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJMoa1404599","article-title":"Valganciclovir for symptomatic congenital cytomegalovirus disease","volume":"372","author":"Kimberlin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2021.105083_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(03)00192-6","article-title":"Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial","volume":"143","author":"Kimberlin","year":"2003","journal-title":"J. Pediatr."},{"key":"10.1016\/j.antiviral.2021.105083_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijid.2013.12.010","article-title":"Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries","volume":"22","author":"Lanzieri","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2021.105083_bib33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/cid\/ciq241","article-title":"Prospective identification of congenital cytomegalovirus infection in newborns using real-time polymerase chain reaction assays in dried blood spots","volume":"52","author":"Leruez-Ville","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2021.105083_bib34","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1517","article-title":"Intelligence and academic achievement with asymptomatic congenital cytomegalovirus infection","volume":"140","author":"Lopez","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.antiviral.2021.105083_bib35","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMra050700","article-title":"Newborn hearing screening--a silent revolution","volume":"354","author":"Morton","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2021.105083_bib36","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1093\/infdis\/jiz443","article-title":"Natural history of congenital cytomegalovirus infection in highly seropositive populations","volume":"221","author":"Mussi-Pinhata","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2021.105083_bib37","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1086\/600882","article-title":"Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population","volume":"49","author":"Mussi-Pinhata","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2021.105083_bib38","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJMoa043337","article-title":"Passive immunization during pregnancy for congenital cytomegalovirus infection","volume":"353","author":"Nigro","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2021.105083_bib39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1067\/mpd.2001.112061","article-title":"Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection","volume":"138","author":"Noyola","year":"2001","journal-title":"J. Pediatr."},{"key":"10.1016\/j.antiviral.2021.105083_bib40","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"Pass","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.antiviral.2021.105083_bib41","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/cid\/ciz019","article-title":"Prevalence of congenital cytomegalovirus infection and associated risk of in-utero HIV acquisition in a high HIV prevalence setting, South Africa","volume":"69","author":"Pathirana","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.antiviral.2021.105083_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2019-3945","article-title":"Vestibular, gaze, and balance disorders in asymptomatic congenital cytomegalovirus infection","volume":"147","author":"Pinninti","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.antiviral.2021.105083_bib43","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/INF.0000000000001194","article-title":"Clinical predictors of sensorineural hearing loss and cognitive outcome in infants with symptomatic congenital cytomegalovirus infection","volume":"35","author":"Pinninti","year":"2016","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.antiviral.2021.105083_bib44","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/INF.0000000000000609","article-title":"Comparison of saliva PCR assay versus rapid culture for detection of congenital cytomegalovirus infection","volume":"34","author":"Pinninti","year":"2015","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.antiviral.2021.105083_bib45","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1093\/infdis\/jiz447","article-title":"The status of vaccine development against the human cytomegalovirus","volume":"221","author":"Plotkin","year":"2020","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.antiviral.2021.105083_bib46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jpids\/piy027","article-title":"The burden of congenital cytomegalovirus infection: a prospective cohort study of 20 000 infants in Finland","volume":"8","author":"Puhakka","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.antiviral.2021.105083_bib47","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","article-title":"Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy","volume":"17","author":"Rawlinson","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2021.105083_bib48","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ebiom.2015.08.003","article-title":"Prevention of primary cytomegalovirus infection in pregnancy","volume":"2","author":"Revello","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.antiviral.2021.105083_bib49","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/infdis\/jiu263","article-title":"Detection of congenital cytomegalovirus infection by real-time polymerase chain reaction analysis of saliva or urine specimens","volume":"210","author":"Ross","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2021.105083_bib50","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/infdis\/jiy057","article-title":"Contribution of breastfeeding to false-positive saliva polymerase chain reaction for newborn congenital cytomegalovirus screening","volume":"217","author":"Ross","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2021.105083_bib51","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(20)31868-7","article-title":"Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial","volume":"396","author":"Shahar-Nissan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2021.105083_bib52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/clpt.1993.4","article-title":"Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group","volume":"53","author":"Trang","year":"1993","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.antiviral.2021.105083_bib53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1515\/jpm-2020-0301","article-title":"Pregnant women\u2019s knowledge and behaviour to prevent cytomegalovirus infection: an observational study","volume":"49","author":"Vena","year":"2020","journal-title":"J. Perinat. Med."},{"key":"10.1016\/j.antiviral.2021.105083_bib54","article-title":"Cohort study on maternal cytomegalovirus seroprevalence and prevalence and clinical manifestations of congenital infection in China","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.antiviral.2021.105083_bib55","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1086\/516445","article-title":"Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National institute of allergy and infectious diseases collaborative antiviral study group","volume":"175","author":"Whitley","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2021.105083_bib56","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jcv.2006.03.011","article-title":"Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection?","volume":"36","author":"Yamamoto","year":"2006","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2021.105083_bib57","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1128\/AAC.40.9.2202","article-title":"Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group","volume":"40","author":"Zhou","year":"1996","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354221000735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354221000735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:33:58Z","timestamp":1759062838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354221000735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":57,"alternative-id":["S0166354221000735"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2021.105083","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcome and the role of antivirals in congenital cytomegalovirus infection","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2021.105083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105083"}}